Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome

Vaccine

Volumn 27, Issue 3, 2009, Pages 473-482

  Dwivedi, Varun ^a   Vasco, Azevedo ^b   Vedi, Satish ^c   Dangi, Anil ^c   Arif, Khan ^d   Bhattacharya, Shailja Mishra ^c   Owais, Mohammad ^d  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

^d ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Adjuvant; Cellular immunity; Humoral immunity; Saccharosome; Vaccine

Indexed keywords

B7 ANTIGEN; BACTERIAL ANTIGEN; CD86 ANTIGEN; CYTOKINE; DRUG VEHICLE; GAMMA INTERFERON; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; LIPOSOME; SACCHAROSOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOL; DELAYED HYPERSENSITIVITY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PLASMODIUM; PLASMODIUM YOELII NIGERIENSIS; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-4; LIPOSOMES; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMODIUM YOELII;

EID: 57749183659     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.054     Document Type: Article

References (62)

1. UNDP/World Bank/WHO special Programme for Research and Training in Tropical Disease. Tropical disease research thirteenth programme report. Geneva, Switzerland: World Health Organization; 1997. p. 40-61.
2. Cohen J. Bumps on the vaccine road. Science 265 (1994) 1371-1380
3. Day K., and Marsh P.K. Naturally acquired immunity to Plasmodium falciparum. Immunol Today 12 (1991) A68-A71
4. Hunter K.L., Kidd M.R., Oisen M.R., Patterson P.S., and Lal A.A. Induction of long lasting immunity to Plasmodium yoelii malaria with the whole blood stage antigens and copolymer adjuvants. J Immunol 154 (1995) 1762-1769
5. McColm A.A., Bomford R., and Dalton L. A comparison of saponin for the potentiation of protective immunity by killed Plasmodium yoelii vaccine in the mouse. Parasite Immunol 4 (1982) 337-347
6. Playfair J.H.L., De Souza J.B., and Cottrell B.J. Protection of mice against malaria by a killed vaccine: differences in effectiveness against Plasmodium yoelii and Plasmodium berghei. Immunology 33 (1997) 507-515
7. Playfair J.H.L., and De Souza J.B. Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clin Exp Immunol 67 (1987) 5-10
8. Len Hagen T.M.L., Sulzer A.J., Kidd M.R., Lal A.A., and Hunter R.L. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. J Immunol 151 (1993) 7077-7085
9. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., and Krieg A.M. CpG is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 160 (1998) 870-876
10. Langhorne J., Quin S.J., and Sanni L.A. Mouse models of bloodstage malaria infections: immune responses and cytokines involved in protection and pathology. In: Perlmann P., and Troye-Blomberg M. (Eds). Malaria immunology (2002), Karger, Basel, Switzerland 204-228
11. Mohan K., and Stevenson M.M. Acquired immunity to asexual blood stages. In: Sherman I.W. (Ed). Malaria: parasite biology, pathogenesis, and protection (1998), American Society Microbiology, Washington, DC 467-493
12. Owais M., and Gupta C.M. Liposome mediated cytosolic delivery of macromolecules and its possible use in vaccine development. Eur J Biochem 267 (2000) 3946-3956
13. Owais M., Masood A.K., Agrewala J.N., Bisht D., and Gupta C.M. Use of liposomes as an immunopotentiating delivery system: in perspective of vaccine development. Scand J Immunol 54 (2001) 125-132
14. Stubbs A.C., Martin K.S., Coeshott C., Skaates S.V., Kuritzkes D.R., Bellgrau D., et al. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell mediated immunity. Nat Med 5 (2001) 625-629
15. Bernstein M.B., Chakraborty M., Wansley E.K., Guo Z., Franzusoff A., Mostbock S., et al. Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine 26 (2008) 509-521
16. Dutta G.P., and Pandey A. Selection of multiple drug and antibiotic resistant strains of rodent malaria parasite Plasmodium yoelii nigeriensis. Abstract second Asian congress of parasitology. Lucknow India (1986) p. 9
17. Hoffman E.J., Weidanz W.P., and Long C.A. Susceptibility of CXB recombinant inbred mice to murine Plasmodia. Infect Immun 43 (1984) 981-985
18. Singleton W.S., Gray M.S., and Brown M.L. A method for adsorbent fractionation of cottonseed oil for experimental intravenous fat emulsions. J Am Oil Chem Soc 42 (1965) 53-56
19. Kumar A., and Gupta C.M. Red cell membrane abnormalities in chronic myeloid leukemia. Nature 303 (1983) 632-633
20. Eling W. Ficoll fractionation for the separation of parasitized erythrocytes from malaria infected blood. Bull WHO 55 (1977) 105-114
21. Sharma KS, Farah D, Bhattacharya-Mishara S, Bajpai P, Agarwal A, Owais M. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice. Vaccine 2006; 24: 948-56.
22. + cell responses with our antibody formation. J Immunol 149 (1992) 1334-1339
23. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 2 (1970) 59-65
24. Misra S., Singh D.P., Dikshit M., and Chatterjee R.K. Functional antigenic molecules of different life stages of rodent filariid. A. viteae and their cross reactivity with human filariae (W. banchrofti) sera. Trop Med 36 (1994) 35
25. Agrewala J.N., Owais M., Gupta C.M., and Mishra G.C. Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: evidence or preferential expansion of Th-2 cells, cytokines. Mol Ther 2 (1996) 59-65
26. Agrewala J.N., Sumit S., Verma R.K., and Mishra G.C. Differential effect of anti-B 7.1 and anti M 150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages. J Immunol 160 (1998) 1067-1077
27. Ha H.C., Woster P.M., Yager J.D., and Casero Jr. R.A. Proc Natl Acad Sci USA 94 (1997) 11557-11562
28. Mallik AI, Singha H, Khan S, Anwar T, Ansari MA, Khalid R, et al. Escheriosome-mediated delivery of recombinant ribosome L7/L12 protein confers protection against murine brucellosis. Vaccine 2007; 25 (46): 7873-7884.
29. Kirkland R.A., and Franklin J.L. J Neurosci 21 (2001) 1949-1963
30. Royall J.A., and Ischiropoulos H. Arch Biochem Biophys 302 (1993) 348-355
31. Nickell S.P., Strykser G.A., and Arevalo C. Isolation from Trypanosoma crusi infected mice of CD8+ MHC-restricted cytotoxic T cells that lyse parasitic infected target cells. J Immunol 150 (1993) 1446-1457
32. Desowitz R.S. Plasmodium berghei: immunogenic enhancement of antigen by adjuvant addition. Exp Parasitol 36 (1975) 6-13
33. Kumar S., Gorden J., Flym J.L., Berzofsky J.A., and Miller L.H. Immunization of mice against Plasmodium vinckei with a combination of attenuated Salmonella typhimurium and malarial antigen. Infect Immun 58 (1990) 3425-3429
34. Mitchell G.H., Richards W.H.G., Voller A., Districh F.M., and Dukor P. Nor-MDP, saponin, corynebacteria, and pertusis organisms as immunological adjuvants in experimental malaria vaccination of macaques. Bull WHO 57 Suppl. 1 (1979) 189-197
35. Murphy J.R., and Lefford M.J. Host defenses in murine malaria: induction of a protracted state of immunity with a formalin-killed Plasmodium berghei blood parasite vaccine. Infect Immun 22 (1978) 798-803
36. Siddiqui W.A. An effective immnization of experimental monkeys against a malaria parasite, Plasmodium falciparum. Science 197 (1977) 388-389
37. Siddiqui W.A., Taylor D.W., Kan S.C., Kramer K., Richmond-Crum S.M., Kotani S., et al. Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant. Science 201 (1978) 1237-1239
38. Polt-Frank F., Zurbriggen R., Helg A., Stuart F., Robinson J., Gluck R., et al. Use of reconstituted influenza virus as an immuopotentiating delivery system for a peptide based vaccine. Clin Exo Immunol 117 (1999) 496-503
39. Lee K.Y., Chun E., and Seong B.L. Investigation of antigen delivery route in vivo and immune-boosting effects mediated by pH sensitive liposome encapsulated with K(b)-restricted CTL epitope. Biochem Biophys Res Commun 292 3 (2002) 682-688
40. Kuninsawa T., Nakagawa S., and Mayumi T. Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development. Adv Drug Deliv Rev 52 (2001) 177-186
41. Ahmad N., Masood A.K., and Owais M. Fusogenic potential of prokaryotic membrane lipids: implication in vaccine development. Eur J Biochem 268 (2001) 5667-5675
42. Siegrist C.A., Plotnicky-Gilquin H., Cordova M., Berney M., Bonnefoy J.Y., Ngayen T.N., et al. Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies. J Infect Dis 179 (1999) 1326-1333
43. De Rossel R.A., Bray R.S., and Alexander J. The correlation between delayed type hypersensitivity. Lymphocyte activation and protective immunity in experimental murine leishmanosis. Parasite Immunol 9 (1987) 106-115 45.42
44. Bretscher P.A., Wel G., Menon J.N., and Bielefeldt-Ohmann H. Establishment of soluble cell mediated immunity that makes susceptible mice resistant to Leishmania major. Science 257 (1992) 539-542
45. Snapper C.M., and Paul W.E. Interferon-gamma and B-cell stimulatory factor-1 reciprocally regulate IgG isotype production. Science 236 (1987) 944-947
46. Gregorides G. Immunological adjuvants: a role for liposomes. Immunol Today 11 (1990) 89-97
47. Qussoren C., and Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev 50 (2001) 143-156
48. Finkelman F.D., Katna I.M., Mossmann T.R., and Coffiman R.L. IFN-γ regulates the isotypes of IgG secreted during in-vivo humoral immune response. J Immunol 140 (1988) 1022-1027
49. + T cell subsets. Cell Immunol 129 (1990) 80-89
50. Stevenson M.M., Tam M.F., Wolfe S.F., and Sher A. IL-12 induced protection against blood stage Plasmodium chabaudi as requires IFN-γ and TNF-α and occurs via a nitric oxide dependent mechanism. J Immunol 155 (1995) 2545-2556
51. + T cells in the immune response to Plasmodium chabaudi. Parasitol Today 5 (1989) 362-364
52. Stevenson M.M., and Tam M.F. Differential induction of helper T cells subsets during blood stage Plasmodium chabaudi as infection in resistant and susceptible mice. Clin Exp Immunol 92 (1993) 77-83
53. Lee S.H., Crocker P., and Gordon S. Macrophage plasma membrane and secretary properties in murine malaria. Effects of Plasmodium yoelii blood-stage infection on macrophages in liver, spleen and blood. J Exp Med 163 (1986) 54-74
54. Playfair J.H.L., Dockrell H., and Taverne J. Macrophages as effector cells in immunity to malaria. Immunol Lett 11 (1985) 233-237
55. Karupiah G., Hunt N.H., King N.J., and Chaudhari G. NADPH oxidase, Nrample and nitric oxide synthase 2 in the host antimicrobial response. Rev Immunogenet 2 (2000) 387-415
56. Verhoeven A.J. The NADPH oxidase: lesions from chronic granulomatous disease neutrophils. Ann NV Acad Sci 832 (1997) 85-92
57. Rockett K.A., Awburn M.M., Cowden W.B., and Clark I.A. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun 59 (1991) 3280-3283
58. Favve N., Ryffel B., and Ruden W. The development of murine cerebral malaria does not require nitric oxide production. Parasitology 118 (1999) 135-138
59. Dascombe M.J., and Nahrevanian H. Pharmacological assessment of the role of nitric oxide in mice infected with what and non lethal species of malaria. Parasitic Immun 25 (2003) 149-159
60. Jacobs P., Radzioch D., and Stevenson M.M. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood stage malaria in mice. J Immunol 155 (1995) 5306-5313
61. Vander Heyde H.C., Gu Y., Zhang Q., Sun G., and Grishan M.B. Nitric oxide is neither necessary nor sufficient for resolution of Plasmodium chabaudi malaria in mice. J Immunol 165 (2000) 3317-3323
62. Darrah P.A., Hondalus M.K., Chen Q., Ischiropoulos H., and Mosser D.M. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun 68 (2000) 3587-3593